Tofacitinib versus Biologic Treatments in Moderate-to-Severe Rheumatoid Arthritis Patients Who Have Had an Inadequate Response to Nonbiologic DMARDs: Systematic Literature Review and Network Meta-Analysis

Objective. To compare the efficacy and tolerability of tofacitinib, an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA), as monotherapy and combined with disease-modifying antirheumatic drugs (DMARDs) versus biological DMARDs (bDMARDs) and other novel DMARDs for second-line...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Rheumatol
Main Authors: Bergrath, Evelien, Gerber, Robert A., Gruben, David, Lukic, Tatjana, Makin, Charles, Wallenstein, Gene
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2017
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5362710/
https://ncbi.nlm.nih.gov/pubmed/28377787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8417249
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados